Pharsight

Drugs that contain Vancomycin

1. Vancomycin patents expiration

VANCOMYCIN's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10849956 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US10188697 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US10039804 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US11000567 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

US11517609 XELLIA PHARMS APS Glycopeptide compositions
Nov, 2035

(11 years from now)

Market Authorisation Date: 26 August, 2021

Treatment: Method of treating bacterial infections

Dosage: SOLUTION;INTRAVENOUS, ORAL

More Information on Dosage

VANCOMYCIN family patents

Family Patents